Skip to main content
Equibles

ADAR1 Capital Management, LLC

Position in DMRA — Damora Therapeutics, Inc.

CIK 1940272 AUSTIN, TX
Back to DMRA Full portfolio

Position in DMRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,282,800
+$56,700 QoQ
Shares Held
280,000
+0.4% QoQ
Ownership
0.454%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#33
of 104 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DMRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. DMRA ranks #58 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,804,703 $240,494,721
2 PTGX
Protagonist Therapeutics, Inc
 960,863 $117,782,586
3 ROIV
Roivant Sciences Ltd.
 3,157,008 $111,726,513
4 IMVT
Immunovant, Inc.
 2,330,716 $89,802,487
5 ZLAB
Zai Lab Ltd
 3,369,034 $64,011,646
6 AGIO
Agios Pharmaceuticals, Inc.
 1,288,053 $47,799,646
7 CRNX
Crinetics Pharmaceuticals, Inc.
 1,222,080 $45,730,233
8 CYTK
Cytokinetics Inc
 457,907 $39,009,097

All Filings in DMRA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,282,800 280,000
2026-03-31 $7,226,100 279,000